Veraxa Biotech stock rises after naming Raju Willener as CFO

VERAXA Biotech AG (NASDAQ: VRXA) appointed Carl von Halem as interim CFO, effective immediately, succeeding Torsten Bürgermeister. The company said it is in the final stages of discussions with a successor and will update the market later. The release cites von Halem’s prior CFO role at Xlife Science and other life-sciences experience.

Meridian Hedged Equity Fund highlighted ACV Auctions (ACVA) in its Q2 2026 investor letter, noting its record Q1 results, $100M share repurchase plan, and AI-driven solutions. ACVA's stock declined 10.19% over the past month and 43.27% over the past year, with a market cap of $1.14B. The fund holds ACVA, citing its market share gains and strong fundamentals.

Intellia Therapeutics (NTLA) secured a $400 million debt facility from OrbiMed, with $75 million funded at closing and $225 million tied to milestones for lonvo-z, a CRISPR gene-editing therapy. The facility provides financial flexibility for lonvo-z's development and potential U.S. launch for hereditary angioedema (HAE). NTLA shares are up 0.63% at $12.76.

Meridian Hedged Equity Fund reported a 4.50% gain in Q2 2026, lagging the S&P 500. The fund highlighted GLOBALFOUNDRIES (GFS) for its strong performance, driven by 30%+ revenue growth in its CID segment and a new dividend policy. GFS shares are up 33.76% over the past year, with a market cap of $24.43 billion.

General Mills (GIS) completed the sale of its Brazil business to 3coracoes, part of a strategy to focus on higher-growth brands. The deal includes brands Yoki and Kitano. Since 2018, acquisitions and divestitures have reshaped about one-third of its net sales. The company expects to use proceeds for debt reduction. Fiscal 2026 net sales declined 5% to $18.4 billion, with fiscal 2027 organic net sales projected to range from down 1.5% to up 0.5%. GIS shares have gained 22% over the past three mon

Southern Company (SO) received approval for a 25-year deal to serve OpenAI's 3.2GW data center in Georgia. OpenAI will cover infrastructure costs, with Georgia Power projecting $950M annual rate relief from 2029-2031 for customers. The deal includes up to 1GW of flexible demand response, but bears note concentration risk and grid reliability concerns.